Screening of antigenic vesicular fluid proteins of Echinococcus multilocularis as potential viability biomarkers to monitor drug response in alveolar echinococcosis patients - Archive ouverte HAL Access content directly
Journal Articles PROTEOMICS - Clinical Applications Year : 2017

Screening of antigenic vesicular fluid proteins of Echinococcus multilocularis as potential viability biomarkers to monitor drug response in alveolar echinococcosis patients

Benoit Valot
Bruno Gottstein

Abstract

The only drugs available to treat alveolar echinococcosis (AE) are mostly parasitostatic and in many cases prescribed for life. Decision criteria for discontinuation rely on the absence of parasitic viability. The aim of the present study is to search for candidate proteins that may exhibit good potential as biomarkers for viability.
No file

Dates and versions

hal-01667558 , version 1 (19-12-2017)

Identifiers

Cite

Benoit Valot, Bénédicte Rognon, Anais Prenel, Alice Baraquin, Jenny Knapp, et al.. Screening of antigenic vesicular fluid proteins of Echinococcus multilocularis as potential viability biomarkers to monitor drug response in alveolar echinococcosis patients. PROTEOMICS - Clinical Applications, 2017, ⟨10.1002/prca.201700010⟩. ⟨hal-01667558⟩
107 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More